MAPT and Alzheimer disease: Levels of CSF Aβ42, t-tau and p-tau have been associated with cognitive performance in patients with AD and mild cognitive impairment16,17 and levels of NFL in CSF have been shown to correlate to cognitive performance in patients with multiple sclerosis18.